Format

Send to

Choose Destination
Toxicol Lett. 2019 Sep 15;312:222-227. doi: 10.1016/j.toxlet.2019.05.018. Epub 2019 May 25.

Occurrence, toxicity and endocrine disrupting potential of Bisphenol-B and Bisphenol-F: A mini-review.

Author information

1
Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, 202002, India.
2
Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, 202002, India. Electronic address: masoodamua@rediffmail.com.

Abstract

Recent imposition of restriction on the use of Bisphenol-A (BPA) paved the way for entry of its analogues in the market. Bisphenol-B and Bisphenol-F are the major analogues of commercial value. Thus, their increasing production and application make them vulnerable to human exposure. Since these analogues have been recently reported to show toxic properties similar to BPA, so they have attracted remarkable scientific attention. This mini-review summarizes the recent reports on the occurrence, toxicity and endocrine disruption of these two BPA analogues.

KEYWORDS:

Bisphenol-A analogues; Bisphenol-B; Bisphenol-F; Endocrine disruption

PMID:
31136786
DOI:
10.1016/j.toxlet.2019.05.018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center